Products
Latest Partnered Companies
.jpg){kind=logo}
Projects
Estimated Cost :
€165 Million
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain
BD to build a €165 million high-tech manufacturing facility in the city of Zaragoza, located in the Aragon region of Spain
Estimated Cost :
-
Samsung Biologics Constructs Super Plant 4 in South Korea
Samsung Biologics plans to open the most innovative biomanufacturing facility with the addition of super plant 4. The modern super plant 4 will be loc...
Estimated Cost :
€400 million
Sanofi to invest €400 million to Create a Unique Vaccine Production Site in Singapore
Sanofi announced a €400 million investment over five years to create a unique vaccine production
Estimated Cost :
$150 Million
KBI Biopharma Invests $150 Millionto Expand Commercial Manufacturing Facility in North California
KBI Biopharma, Inc, plans to open a new facility for commercial manufacturing. The manufacturing site involves an investment of US$150 million. The fa...
Press Release
Reven Pharmaceuticals Reports a Promising Second Generation Formulation of Its Lead Anti-sepsis Drug Candidate Rejuveinix (RJX)
Reven Holdings, Inc. is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for sepsis, cancer, viral illnesses, including COVID-19 - and inflammatory disorders. Reven today announced the publication of a peer
Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab
Amneal Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for Bevacizumab, pursuant to Section 351(k) pathway of the Public Health Service Act, and with a standard review goal date in the second quarter of 2022 according to the BsUFA
Irrimax Receives FDA Clearance for Irrisept® as an Antimicrobial Wound Lavage for US Market
Irrimax Corporation, manufacturer of Irrisept, announces new clearance from the U.S. Food and Drug Administration (FDA), making Irrisept the only self-contained irrigation system for antimicrobial wound lavage in the U.S. market. Today, more than 2,000 U.S. hospitals are using the Irrisept product totaling more than 2 million lifetime uses.
InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma
InnoCare, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its pan-FGFR inhibitor gunagratinib (ICP-192) for the treatment of cholangiocarcinoma.
Events
6th World Conference on Applied Microbiology and Beneficial Microbes
International Conference on Pharmaceutics and Drug Discovery
23nd International Conference on Advanced Energy Materials and Research
Articles
Top 12 Analytical Lab Equipments in Pharmaceutical Industry
The analytical lab equipments or instruments are used in analytical applications in pharmaceutical, food-processing laboratories
A Complete Guide on Blister Packaging Machine
Packaging machinery is one of the vital equipment in the pharmaceutical industry, food processing, and chemical
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Focus on drug discovery and development has shifted away from small to large, complex molecular entities
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
See your banner here...
.jpg)
Thank you for contacting us. One of our support staff will get in touch with you shortly.
Happy Surfing!
Regards,
Client Success Team (CRM),
